Deerfield Management Company — 2020 Investments
5 investments dated 2020 · listed companies and verified rows first · show all
Jewel is a wearable patch cardioverter defibrillator designed to provide continuous protection from sudden cardiac arrest, using machine learning to minimize false alarms while requiring no daily maintenance for up to a week.
AI & Machine LearningHealthtechMedical DevicesSan Francisco, US
Uday N. Kumar(Executive Officer, Director)
BoardRussell Hirsch(Director)Neil Exter(Director)inKrishna Yeshwant(Director)inWilliam H. Kucheman(Director)William Kucheman(Director)
Board seatAndrew ElBardissi· per SEC Form D · $145.6M raise · filed Mar 2020
Co-investorsThird Rock VenturesGV (Google Ventures)
Incardatherapeutics develops drug therapies for treating atrial fibrillation using synergistic combinations of anti-arrhythmic agents, with delivery platforms designed for both hospital and at-home settings.
BiotechDigital HealthMedical DevicesBrisbane, US
Rangachari Narasimhan(Executive Officer, Director)Grace Colon(Executive Officer, Director)Miller Samantha(Executive Officer)Carlos A. Schuler(Executive Officer, Director)John S. Patton(Executive Officer, Director)
BoardMcCarthy Reenie(Director)
Board seatAndrew ElBardissi· per SEC Form D · $50M raise · filed Oct 2020
Co-investorsAsset Management CompanyHealthCapSofinnova Ventures
HealthtechWoburn, US
Alan Abrams(Executive Officer, Director)Vince Cook(Executive Officer)Peter Dunphy(Executive Officer, Director)Douglas Thompson(Executive Officer, Director, Promoter)Craig Bass(Executive Officer)Jennifer Bryant(Executive Officer)
Board seatSteve AnastosJulian Harris· per SEC Form D · $45M raise · filed Sep 2020
Reprieve Cardiovascular develops a decongestion management system that uses real-time patient data to guide and personalize diuretic therapy for fluid removal in heart failure patients.
Digital HealthHealthtechMedical DevicesMilford, US
Tony Fields(Executive Officer)Adam Bartnik(Executive Officer)Mark Pacyna(Executive Officer, Director)inJim Dillon(Executive Officer, Director)Hanson S. Gifford III(Director)Gregory W Mann(Executive Officer)
Board seatAndrew ElBardissi· per SEC Form D
Co-investorsArboretum VenturesLightstone VenturesRex Health VenturesGenesis Venture CapitalSante Ventures
HealthtechTrumbull, US
Jia Jia Ye(Executive Officer, Director)Alexa Rachlin(Director)Missy Krasner(Director)
Board seatSteve AnastosJulian Harris· per SEC Form D · $18.1M raise · filed Nov 2020
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.